Impero (IMPERO) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
27 Jul, 2026Executive summary
Achieved best Q3 ever for net new ARR, with DKK 2.4M added and total ARR reaching DKK 43.2M, up 17% year-over-year, driven by strong DACH performance and churn below 1%.
Revenue increased 15% year-over-year in Q3 2025 to DKK 10.5M, with nine-month revenue up 19% year-over-year.
Positive EBITDA of DKK 1.0M in Q3 2025, reversing a loss in the prior year.
Six new customers added, strong upsell activity, and first paying customers onboarded for the Control Testing module.
Solid cash position of DKK 5.3M at quarter-end, with ongoing efforts to strengthen capital.
Financial highlights
Gross profit margin reached 98% in Q3 2025, up from 96% in Q3 2024; contribution margin improved to 97%.
Staff costs rose 19% in Q3, with a 28% reduction in other external expenses; for nine months, staff costs increased 8% and other external expenses 7%.
Free cash flow to net new ARR ratio (12M rolling) was negative at 1.5, with expectations for improvement by year-end.
Net ARR growth YTD was DKK 4.4M, down from DKK 6.5M in the prior year.
EBITDA for nine months was DKK -3.2M, improved from DKK -6.7M last year.
Outlook and guidance
2025 ARR guidance set at DKK 43M to 46M, aiming for the upper end, with annual ARR growth of 11–19%.
EBITDA guidance improved to DKK -5M to -3M for 2025.
Targeting recurring cash flow positivity by end of 2026.
Guidance assumes stable macroeconomic and geopolitical conditions.
Continued focus on revenue retention and expansion within the existing customer base.
Latest events from Impero
- 28% ARR and 29% revenue growth, improved EBITDA, and strong DACH expansion in H1 2024.IMPERO
Q2 202427 Jul 2026 - 31% ARR growth, strong retention, and positive cash flow highlight robust Q3 performance.IMPERO
Q3 202427 Jul 2026 - 28% ARR growth, improved EBITDA, and reduced churn set the stage for strong 2025 guidance.IMPERO
Q4 202427 Jul 2026 - 24% ARR growth, 27% revenue rise, and strong retention highlight robust Q1 2025 performance.IMPERO
Q1 202527 Jul 2026 - ARR up 15% to DKK 40.7M, revenue up 21%, EBITDA loss narrows, guidance maintained.IMPERO
Q2 202527 Jul 2026 - ARR grew 19% to DKK 46.2M in 2025, with EBITDA improving and churn at a low 1%.IMPERO
Q4 202527 Jul 2026 - 20% ARR growth, positive EBITDA, and strong DACH momentum drive upgraded 2026 outlook.IMPERO
Q1 202627 Jul 2026 - Entity Management, AI features, and Control Health drive upcoming platform enhancements.IMPERO
Investor update24 Jun 2026 - Strong ARR growth, AI-driven strategy, and all board proposals approved amid market uncertainties.IMPERO
AGM 202615 Apr 2026